The US Food and Drug Administration (FDA) has granted emergency use authorisation (EUA) to a new high-pressure ventilator developed by Nasa engineers to treat Covid-19 patients.
Developed at Nasa’s Jet Propulsion Laboratory (JPL) in Southern California, US, the ventilator is called Ventilator Intervention Technology Accessible Locally (VITAL).
Go deeper with GlobalData
The launch of the new ventilator is expected to free up the country’s limited supply of traditional ventilators so they may be used on patients, showing the most severe symptoms of Covid-19.
The Office of Technology Transfer and Corporate Partnerships at Caltech, which manages JPL, is offering a free license for VITAL. It is also in discussions with commercial medical industry to find manufacturers for the device.
Nasa administrator Jim Bridenstine said: “This FDA authorisation is a key milestone in a process that exemplifies the best of what government can do in a time of crisis.
“This ventilator is one of countless examples of how taxpayer investments in space exploration, the skills, expertise and knowledge collected over decades of pushing boundaries and achieving firsts for humanity translate into advancements that improve life on Earth.”
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataLast month, the VITAL prototype passed a critical test at the Icahn School of Medicine at Mount Sinai in New York before securing the EUA.
Nasa said that the ventilator can be built faster and maintained more easily compared to a traditional ventilator.
Furthermore, it can be modified for use in field hospitals being set up in convention centres, hotels and other high-capacity facilities due to its flexible design.
VITAL is developed to last three or four months and cannot replace current hospital ventilators, which can last years and are built to address a broader range of medical issues.
